I.BarbosaM
doi: 10.1067/mlc.2002.129505
We are confident in the quality of our Liposomal Glutathione and the health benefits it provides
PD-1/PD-L1 checkpoint-blocking antibodies are thought to act primarily in the tumor microenvironment, where PD-L1 is expressed by tumor cells (174), myeloid cells (168, 203, 204), LECs (94, 95, 98), blood endothelial cells (95), B cells (205, 206), T cells (207), dendritic cells (203) and NK cells (208, 209)
The process looks like this: Initial consultation and 80+ biomarker panel to establish baseline Provider review of labs, health history, and current diet 60-minute visit to go over every result and build a combined plan Peptide protocol matched to your specific goals (body composition, recovery, gut health, aging) Nutrition adjustments targeted to the deficiencies and patterns found in your labs Ongoing monitoring with follow-up labs to track response and adjust Our team of 7 providers works across functional medicine, hormone optimization, and peptide therapy, so you get a treatment plan that connects all the pieces instead of treating each one in isolation
THF = tetrahydrofolate
